Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,237 across all filing types
Latest filing 2025-12-09 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Allotment of Securities
Share Issue/Capital Change Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the allotment of shares under the company's Employee Stock Options Plan (ESOP) 2019. It details the number of shares allotted, the increase in issued share capital, and compliance with SEBI regulations. The document includes specifics such as share numbers, exercise price, lock-in period, and regulatory references. It is an announcement of a share allotment event related to employee stock options, which is a capital change event. The document is relatively short (4152 characters) and serves as a formal notification rather than a detailed financial report or analysis. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2025-12-09 English
Please find enclosed herewith intimation regarding incorporation of step down wholly owned subsidiary of Bliss GVS Pharma Limited.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges about the incorporation of a wholly owned subsidiary by the company. It includes a detailed disclosure as per SEBI circulars about the new subsidiary, its share capital, ownership, and incorporation details. There are no financial statements or performance data, nor is this a report or earnings release. It is a regulatory announcement about a corporate action (incorporation of a subsidiary) required to be disclosed under listing regulations. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-11-25 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges about the incorporation of a wholly owned subsidiary by the company. It includes a detailed disclosure as per SEBI circulars about the new subsidiary, its share capital, ownership, and incorporation details. There are no financial statements or performance data, nor is this a report or earnings release. It is a regulatory announcement about a corporate action (incorporation of a subsidiary) required to be disclosed under listing regulations. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2025-11-25 English
Please find enclosed herewith the copies of newspaper advertisement published pertaining to ongoing bi-monthly communications regarding the Special Window for Re-Lodgement of Transfer Requests ....
Regulatory Filings
2025-11-24 English
Copy of Newspaper Publication
Regulatory Filings Classification · 72% confidence The document is an intimation to the stock exchanges under SEBI LODR Regulation 47 advising that the company’s newspaper advertisement regarding the “Special Window for Re-lodgement of Transfer Requests of Physical Shares” has been published. It is not a financial report (e.g., annual/quarterly report), not a dividend or voting announcement, nor a management change notice, but a routine regulatory disclosure. This fits the general fallback category for miscellaneous regulatory announcements (RNS).
2025-11-24 English
Please find attached herewith the newspaper publication regarding Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025
Regulatory Filings
2025-11-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.